3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
13
Lung Neoplasms
7
Stomach Neoplasms
3
Adenocarcinoma Of Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Neoplasm Metastasis
2
Esophageal Neoplasms
2
Adenocarcinoma
2
Sarcoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Metastatic Gastric Adenocarcinoma
1
Head and Neck Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Advanced Gastric or EGJ Cancer
1
Interventions
Gemcitabine
8
Cisplatin
8
pembrolizumab
4
durvalumab
4
Specimen Handling
3
Platinum
3
Oxaliplatin
3
Leucovorin
3
1,2-diaminocyclohexaneplatinum II citrate
3
Taxes
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Folfox protocol
2
Fluorouracil
2
Biopsy
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
zanidatamab
1
trastuzumab deruxtecan
1
tivozanib
1
peposertib
1
guadecitabine
1
fludarabine
1
dehydroftorafur
1
binimetinib
1
avelumab
1
atezolizumab
1
Trastuzumab
1
Radiation Dose Hypofractionation
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Ramucirumab
×
90 days
×
Clear all
No trials found.